Health
Novel Approach for Intravenous Cancer Immunotherapy – Genetic Engineering & Biotechnology News
Researchers report they have developed nanoparticles to deliver STING agonists and metal ions for intravenous cancer immunotherapy….
Researchers at the University of Michigan (U-M) School of Pharmacy and the Rogel Cancer Center took a different approach to boosting the STING pathway. The team observed that adding the nutritional metal ion manganese to STING agonists boosted STING’s tumor-fighting…
Continue Reading